Almokalant

Jump to navigation Jump to search
Almokalant
File:Almokalant.svg
Clinical data
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC18H28N2O3S
Molar mass352.5 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Almokalant

Articles

Most recent articles on Almokalant

Most cited articles on Almokalant

Review articles on Almokalant

Articles on Almokalant in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Almokalant

Images of Almokalant

Photos of Almokalant

Podcasts & MP3s on Almokalant

Videos on Almokalant

Evidence Based Medicine

Cochrane Collaboration on Almokalant

Bandolier on Almokalant

TRIP on Almokalant

Clinical Trials

Ongoing Trials on Almokalant at Clinical Trials.gov

Trial results on Almokalant

Clinical Trials on Almokalant at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Almokalant

NICE Guidance on Almokalant

NHS PRODIGY Guidance

FDA on Almokalant

CDC on Almokalant

Books

Books on Almokalant

News

Almokalant in the news

Be alerted to news on Almokalant

News trends on Almokalant

Commentary

Blogs on Almokalant

Definitions

Definitions of Almokalant

Patient Resources / Community

Patient resources on Almokalant

Discussion groups on Almokalant

Patient Handouts on Almokalant

Directions to Hospitals Treating Almokalant

Risk calculators and risk factors for Almokalant

Healthcare Provider Resources

Symptoms of Almokalant

Causes & Risk Factors for Almokalant

Diagnostic studies for Almokalant

Treatment of Almokalant

Continuing Medical Education (CME)

CME Programs on Almokalant

International

Almokalant en Espanol

Almokalant en Francais

Business

Almokalant in the Marketplace

Patents on Almokalant

Experimental / Informatics

List of terms related to Almokalant

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Almokalant is drug used to treat arrhythmia.[1] It is a potassium channel blocker. It has been found to have teratogenic effects in rats.[2]

References

  1. Wiesfeld A C; Crijns H J; Bergstrand R H; Almgren O; Hillege H L; Lie K I (1993). "Torsades de pointes with Almokalant, a new class III antiarrhythmic drug". American heart journal. 126 (4): 1008–1011.
  2. Signs of Almokalant - Teratogenic Agent, wrongdiagnosis.com

Template:Cardiovascular-drug-stub